Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DUPILUMAB for Dermatitis: Side Effects & Safety Data

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

There are 9,959 adverse event reports in the FDA FAERS database where DUPILUMAB was used for Dermatitis.

Most Reported Side Effects for DUPILUMAB

Side Effect Reports % Deaths Hosp.
Pruritus 44,279 11.7% 53 1,105
Dermatitis atopic 33,670 8.9% 27 570
Product use in unapproved indication 33,452 8.8% 317 1,795
Rash 30,895 8.2% 37 874
Injection site pain 27,799 7.3% 15 542
Drug ineffective 23,712 6.3% 38 745
Dry skin 20,239 5.3% 19 371
Eczema 20,020 5.3% 18 469
Product dose omission issue 18,189 4.8% 21 598
Condition aggravated 16,459 4.3% 34 652
Arthralgia 15,176 4.0% 18 577
Inappropriate schedule of product administration 14,927 3.9% 30 509
Asthma 12,312 3.3% 24 1,689
Skin exfoliation 11,738 3.1% 13 323
Dry eye 10,892 2.9% 6 209

Other Indications for DUPILUMAB

Dermatitis atopic (179,563) Asthma (57,014) Eczema (28,882) Nasal polyps (21,908) Eosinophilic oesophagitis (13,948) Neurodermatitis (9,956) Dermatitis allergic (8,136) Psoriasis (5,681) Product used for unknown indication (5,301) Illness (4,122)

Other Drugs Used for Dermatitis

CRISABOROLE (407) APREMILAST (122) TRALOKINUMAB-LDRM (90) KETOCONAZOLE (66) CYCLOSPORINE (62) DOXYCYCLINE (57) PIMECROLIMUS (55) CLOBETASOL (50) RUXOLITINIB (50) TRIAMCINOLONE ACETONIDE (48)

Related Pages

DUPILUMAB Full Profile All Dermatitis Drugs DUPILUMAB Demographics DUPILUMAB Timeline